A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

Pain Management, New York

Long Island Pain Management, Port Jefferson Station

Univ of Rochester, Rochester

Pennsylvania State College of Medicine, Hershey

Lehigh Valley Hosp, Allentown

Thomas Jefferson Univ Hosp, Philadelphia

VA Med Ctr / Oncology Section, Washington D.C.

Johns Hopkins Hosp, Baltimore

Bowman Gray School of Medicine / Wake Forest Univ, Winston-Salem

Emory Univ Hosp, Atlanta

Univ of Miami School of Medicine, Miami

H Lee Moffit Cancer Ctr and Research Institute, Tampa

Northport Hosp, Northport

Ctr for Pain Management and Rehabilitation, Huntsville

Gulf Coast Clinical Services, Mobile

Methodist Hosp, Memphis

Univ of Tennessee, Memphis

Cleveland Clinic Foundation, Cleveland

Elkhardt Gen Hosp, Elkhardt

Neurosurgical Associates, Terre Haute

Minneapolis Veterans Administration, Minneapolis

Cook County Hosp, Chicago

Pain Control Ctr, Chicago

The Pain Institute, Kansas City

Univ of Missouri Med Ctr, Columbia

New Orleans Pharmaceutical Research, Kenner

Holt Krock Clinic, Fort Smith

Texas Tech Univ Health Science Ctr, Lubbock

Alta Bates Hosp, Berkeley

Good Samaritan Hosp Ctr, San Jose

Swedish Pain Management, Seattle

Northwest Neuroscience Institute, Seattle

Fairfax Hosp, Falls Church

Univ of Iowa Hosp, Iowa City

Marschfield Clinic, Marshfield

Univ of Kansas Med Ctr, Kansas City

Louisiana State Univ, Shreveport

Univ of Texas Health Sciences Ctr, San Antonio

Pain Diagnosis and Treatment, Glendora

Univ of CA - San Diego, San Diego

Connecticut Pain Care, Danbury

Brigham and Women's Hosp, Boston

Cooper Hospital Early Intervention Program, Camden

Clinical Solutions, Princeton